Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
With lung cancer FDA nod, it's David versus Goliath
Nuvation Bio has won FDA approval for Ibtrozi, or taletrectinib, to challenge existing meds from Pfizer, BMS and Roche in ROS1-positive lung cancer.
Angus Liu
Jun 11, 2025 4:17pm
Akeso’s Anniko enters crowded US PD-1 market
Apr 25, 2025 10:55am
GSK kicks off Blenrep's market return with first combo nod in UK
Apr 17, 2025 2:29pm
Second Novartis drug in IgAN troika crosses FDA finish line
Apr 3, 2025 10:56am
Sanofi scores FDA nod for Qfitlia for all types of hemophilia
Mar 28, 2025 3:21pm
FDA approves Soleno's Vykat XR for insatiable hunger disorder
Mar 27, 2025 11:24am
